ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
7.91
+0.28 (3.60%)
At close: Dec 5, 2025, 4:00 PM EST
7.90
0.00 (-0.06%)
After-hours: Dec 5, 2025, 6:47 PM EST
ProMIS Neurosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | - | - | 0 | |
| Revenue Growth (YoY) | - | - | - | - | - | 32.47% | |
| Cost of Revenue | 28.34 | 10.64 | 7.88 | 16.09 | 4.63 | 2.5 | |
| Gross Profit | -28.34 | -10.64 | -7.88 | -16.09 | -4.63 | -2.5 | |
| Selling, General & Admin | 3.06 | 2.69 | 5.58 | 5.99 | 3.66 | 1.95 | |
| Operating Expenses | 3.06 | 2.69 | 5.58 | 5.99 | 3.66 | 1.95 | |
| Operating Income | -31.4 | -13.33 | -13.46 | -22.08 | -8.29 | -4.44 | |
| Interest Expense | - | -0.08 | -0.2 | -0.28 | -0.42 | - | |
| Interest & Investment Income | - | - | - | - | - | 0 | |
| Other Non Operating Income (Expenses) | 6.11 | 19.68 | 1.25 | 4.29 | -1.08 | - | |
| EBT Excluding Unusual Items | -25.28 | 6.28 | -12.41 | -18.07 | -9.79 | -4.44 | |
| Other Unusual Items | -4 | -3.5 | -0.8 | 0.01 | - | - | |
| Pretax Income | -29.28 | 2.78 | -13.21 | -18.06 | -9.79 | -4.44 | |
| Net Income | -29.28 | 2.78 | -13.21 | -18.06 | -9.79 | -4.44 | |
| Net Income to Common | -29.28 | 2.78 | -13.21 | -18.06 | -9.79 | -4.44 | |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 65.13% | 115.26% | 63.85% | 29.68% | 21.55% | 9.93% | |
| EPS (Basic) | -20.05 | 2.68 | -26.87 | -60.19 | -42.30 | -23.34 | |
| EPS (Diluted) | -20.05 | 2.68 | -26.87 | -60.19 | -42.30 | -23.34 | |
| Free Cash Flow | -27.55 | -27.18 | -10.84 | -17.04 | -9.31 | -3.5 | |
| Free Cash Flow Per Share | -18.86 | -25.68 | -22.05 | -56.77 | -40.23 | -18.40 | |
| Operating Margin | - | - | - | - | - | -361893.65% | |
| Profit Margin | - | - | - | - | - | -361879.48% | |
| Free Cash Flow Margin | - | - | - | - | - | -285250.81% | |
| EBITDA | - | -13.31 | -13.44 | -22.07 | -8.25 | -4.43 | |
| D&A For EBITDA | - | 0.02 | 0.02 | 0.01 | 0.05 | 0.01 | |
| EBIT | -31.4 | -13.33 | -13.46 | -22.08 | -8.29 | -4.44 | |
| Revenue as Reported | - | - | - | - | - | 0 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.